People who suffer from psoriasis experience scaly, painful rashes and flaking skin. Most people see these breakouts on their knees, elbows, torso or scalp. Scientists aren’t sure what causes psoriasis ...

Knight Therapeutics Inc. (TSX: GUD) ("Knight"), a pan-American (ex-USA) specialty pharmaceutical company, announced today that Health Canada has approved WYNZORA® , a white uniform cream containing 0.

Oral roflumilast showed potential as a nonbiologic systemic therapy for moderate to severe psoriasis, offering an alternative ...

Soligenix reports positive Phase 2a extension results for SGX302 gel in psoriasis, showing improved skin scores and strong ...

Please provide your email address to receive an email when new articles are posted on . Long-term use of a combination halobetasol propionate and tazarotene lotion cleared psoriasis in patients with ...

Psoriasis is a lifelong condition that comes and goes in flares, and the key to managing it is the right treatment. Your dermatologist will help you find a therapy based on: How bad your symptoms are ...

A corticosteroid cream or ointment might be the first treatment you try for plaque psoriasis. Topical steroids are often a doctor's go-to because they're safe and they work, but they're not your only ...

Emirates Drug Establishment Approves Tapinarof Cream 1%, A New Treatment For Plaque Psoriasis In Adults And Atopic Dermatitis ...

Compared to Sotyktu (deucravacitinib), which was approved by the FDA for plaque psoriasis in 2022 and brought in sales of ...

The coprimary endpoints were the proportion of zasocitinib-treated patients achieving static Physician Global Assessment (sPGA) of clear (0) or almost clear (1) and Psoriasis Area and Severity Index ...

Takeda (TAK) on Thursday announced that two pivotal late-stage trials for its oral tyrosine kinase inhibitor zasocitinib ...